Dalteparin-induced alopecia in hemodialysis patients: Reversal by regional citrate anticoagulation [2]

Blood

Volumn 97, Issue 9, 2001, Pages 2914-2915

  Apsner, Robert ^a   Hörl, Walter H ^a   Sunder Plassmann, Gere ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ALOPECIA; ANTICOAGULANT THERAPY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIALYSIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; HAIR GROWTH; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; LETTER; NEPHROBLASTOMA; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0035353190     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.9.2914     Document Type: Letter

References (5)

1. Schrader J, Stibbe W, Armstrong VW, et al. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int. 1988;33:890-896.
2. Pinnik RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983;308:258-261.
3. Apsner R, Buchmayer H, Sunder-Plassmann G, Hörl WH. A simple method for citrate anticoagulation (CA) during high-flux dialysis: experience with 670 dialyses in 34 patients [abstract]. J Am Soc Nephrol. 1999;10:188A.
4. Tosti A, Misciali C, Piraccini B, Peluso A, Bardazzi F. Drug-induced hair loss and hair growth: incidence, management, and avoidance. Drug Safety. 1994;10:310-317.
5. Barnes C, Deidun D, Hynes K, Monagle P. Alopecia and dalteparin: a previously unreported association [letter]. Blood. 2000;96:1618-1619.